Global Neurodegenerative Disease Market Size To Worth USD 90.10 Billion by 2033 | CAGR of 7.84%
Category: HealthcareGlobal Neurodegenerative Disease Market Size To Worth USD 90.10 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Neurodegenerative Disease Market Size is to Grow from USD 42.37 Billion in 2023 to USD 90.10 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 7.84% during the projected period.
Get more details on this report -
Browse key industry insights spread across 255 pages with 121 Market data tables and figures & charts from the report on the "Global Neurodegenerative Disease Market Size, Share, and COVID-19 Impact Analysis, By Disease (Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Multiple Sclerosis), By Route of Administration (Oral, Injectable, Transdermal, Others), By Drug (Cholinesterase Inhibitors, Gene Therapy, NMDA Receptor Antagonists, Dopaminergic Drugs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here https://www.sphericalinsights.com/reports/neurodegenerative-disease-market
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to the loss of neurons and cognitive or motor impairments. Common neurodegenerative diseases include Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis. Treatments for these conditions typically focus on alleviating symptoms and slowing disease progression, as there are currently no cures. Medications such as cholinesterase inhibitors and memantine are used for Alzheimer’s, while dopamine agonists and levodopa are common for Parkinson’s. Additionally, therapies may include physical and occupational therapy, lifestyle modifications, and supportive care to improve the patient's quality of life. Ongoing research is exploring innovative approaches, including disease-modifying therapies, gene therapy, and neuroprotective agents, aiming to provide more effective treatment options in the future.
The Alzheimer's disease segment is anticipated to hold the greatest share of the global neurodegenerative disease market during the projected timeframe.
Based on the disease, the global neurodegenerative disease market is divided into Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis. Among these, the Alzheimer's disease segment is anticipated to hold the greatest share of the global neurodegenerative disease market during the projected timeframe. The segment is predicted to dominate the market due to the aging population, increased research investment, and growing awareness, driving demand for effective treatments and market growth.
The injectable segment is anticipated to grow at the fastest pace in the global neurodegenerative disease market during the projected timeframe.
Based on the route of administration, the global neurodegenerative disease market is divided into oral, injectable, transdermal, and others. Among these, the injectable segment is anticipated to grow at the fastest pace in the global neurodegenerative disease market during the projected timeframe. The injectable segment is predicted to experience the fastest growth in the market due to the increasing adoption of biologics, gene therapies, and monoclonal antibodies.
The gene therapy segment is anticipated to grow at the fastest pace in the global neurodegenerative disease market during the projected timeframe.
Based on the drug, the global neurodegenerative disease market is divided into cholinesterase inhibitors, gene therapy, NMDA receptor antagonists, and dopaminergic drugs. Among these, the gene therapy segment is anticipated to grow at the fastest pace in the global neurodegenerative disease market during the projected timeframe. The gene therapy segment is predicted to experience the fastest growth in the global neurodegenerative disease market due to advancements in genetic research and promising clinical trials and regulatory approvals.
Asia Pacific is expected to hold the largest share of the global neurodegenerative disease market over the forecast period.
Get more details on this report -
Asia Pacific is expected to hold the largest share of the global neurodegenerative disease market over the forecast period. The region is poised to dominate the global neurodegenerative disease market, driven by aging populations, increasing disorders, and growing healthcare infrastructure, requiring innovative treatments.
North America is predicted to grow at the fastest pace in the global neurodegenerative disease market during the projected timeframe. The region, dominated by the US, Canada, and Mexico, is bolstered by a robust healthcare system, advanced research, and significant investments in pharmaceuticals and biotechnology.
Major vendors in the Global Neurodegenerative Disease Market include Biogen Inc., Eli Lilly and Company, Roche Holding AG, Novartis AG, Pfizer Inc., AstraZeneca plc, Bristol-Myers Squibb, Merck & Co., Inc., AbbVie Inc., Amgen Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Neurocrine Biosciences, Inc., Otsuka Pharmaceutical Co., Ltd., and Others.
Recent Developments
- In May 2024, NeuroSense Therapeutics partnered with PhaseV, a leading machine learning company, for the Phase 3 trial of PrimeC, a treatment for ALS.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Neurodegenerative disease Market based on the below-mentioned segments:
Global Neurodegenerative Disease Market, By Disease
- Alzheimer's Disease
- Parkinson's Disease
- Huntington's Disease
- Multiple Sclerosis
Global Neurodegenerative Disease Market, By Route of Administration
- Oral
- Injectable
- Transdermal
- Others
Global Neurodegenerative Disease Market, By Drug
- Cholinesterase Inhibitors
- Gene Therapy
- NMDA Receptor Antagonists
- Dopaminergic Drugs
Global Neurodegenerative Disease Market, Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?